EUVIMEDEUVIMED entdecken
Crossref

Evaluation of the Antiproliferative Effects of a Newly Synthesized Benzimidazole Compound on Prostate Cancer Cells

Esra Bilici, Senem Akkoç

Türk Doğa ve Fen Dergisi · 01.07.2026 · 15 (2) · 190-195

DOI: 10.46810/tdfd.1880931 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Türk Doğa ve Fen Dergisi, online erschienen am 01.07.2026. Verfasst von Esra Bilici und 1 weiteren Autor:innen. Die Arbeit nennt 16 Literaturangaben. Gefördert von: Süleyman Demirel University.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Benzimidazole is a versatile scaffold with considerable anticancer potential due to its structural resemblance to nucleosides and its ability to function as both a hydrogen bond donor and acceptor, enabling interactions with multiple molecular targets involved in cancer progression. Numerous benzimidazole-based anticancer agents have been reported in the literature, highlighting the importance of this core structure. In this study, a novel benzimidazole derivative, SA-17, was synthesized and its anticancer activity was evaluated in the human prostate cancer cell line PC3. Cytotoxic effects were assessed in vitro using the MTT assay. Cellular proliferation was analyzed in PC3 cells following 72 hours of exposure to varying concentrations of SA-17 and the reference drug nilotinib. The results demonstrated significant differences in cell viability depending on the concentration applied. High concentrations of SA-17 (150 µg/mL and above) exhibited strong cytotoxic and antiproliferative effects against PC3 cells after 72 hours of incubation. However, nilotinib showed greater efficacy than SA-17 in reducing PC3 cell viability. Overall, the findings suggest that structural modifications of benzimidazole derivatives hold substantial potential for the development of effective anticancer agents.

Förderung

  • Süleyman Demirel University

Zitieren

APA

Bilici, E., & Akkoç, S. (2026). Evaluation of the Antiproliferative Effects of a Newly Synthesized Benzimidazole Compound on Prostate Cancer Cells. Türk Doğa ve Fen Dergisi, 15(2), 190-195. https://doi.org/10.46810/tdfd.1880931

Vancouver

Bilici E, Akkoç S. Evaluation of the Antiproliferative Effects of a Newly Synthesized Benzimidazole Compound on Prostate Cancer Cells. Türk Doğa ve Fen Dergisi. 2026;15(2):190-195. doi:10.46810/tdfd.1880931

BibTeX
@article{Bilici2026,
  author = {Bilici, Esra and Akkoç, Senem},
  title = {Evaluation of the Antiproliferative Effects of a Newly Synthesized Benzimidazole Compound on Prostate Cancer Cells},
  journal = {Türk Doğa ve Fen Dergisi},
  year = {2026},
  volume = {15},
  number = {2},
  pages = {190--195},
  doi = {10.46810/tdfd.1880931}
}
Kostenlos starten →